A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
59,84 BRL
0,00%
(0,00) 1D
16. lis, 16:56:00 GMT -3 · BRL
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za A1LN34...
Otvori
59,28 BRL
Najviša
59,84 BRL
Najniža
59,28 BRL
Trž. kap.
31,02 mlr.
Prosj. kol.
446,00
Količina
17,00
52-tjed. najviša
131,80 BRL
52-tjed. najniža
50,25 BRL
Dionice u optjecaju
133,81 mil.
Broj djelatnika
2 tis.
Otvori
59,28 BRL
Najviša
59,84 BRL
Najniža
59,28 BRL
Trž. kap.
31,02 mlr.
Prosj. kol.
446,00
Količina
17,00
52-tjed. najviša
131,80 BRL
52-tjed. najniža
50,25 BRL
Dionice u optjecaju
133,81 mil.
Broj djelatnika
2 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 1 dan
Citigroup cuts target to USD 320 for Alnylam Pharmaceuticals stock
BioSpace
·
prije 3 dana
Alnylam bulls and bears fight it out after business-shaking guidance cut
Profil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Alnylam Pharmaceuticals Inc Bdr – informacije
Glavni izvršni direktor-
Zaposlenici2,5 tis.
Osnovano14. lip 2002.
Sjedište-
Sektor-
Web-lokacijaalnylam.com